|
|
|
Volumn 8, Issue 7, 2002, Pages 2188-2192
|
|
Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: A National Cancer Institute of Canada clinical trials group study
a e c d b f g f g |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C RAF KINASE INHIBITOR;
CGP 69846A;
ISIS 3521;
PROTEIN KINASE C INHIBITOR;
RAF PROTEIN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
ENZYME INHIBITOR;
ISOENZYME;
NUCLEOTIDE;
PRKCA PROTEIN, HUMAN;
PROTEIN KINASE C;
PROTEIN KINASE C ALPHA;
ADULT;
ADVANCED CANCER;
AFFECTIVE NEUROSIS;
AGED;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER RECURRENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
ENZYME INHIBITION;
FATIGUE;
FEMALE;
GRANULOCYTOPENIA;
HUMAN;
INFECTION;
MALE;
METASTASIS;
NAUSEA;
PATIENT MONITORING;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STEADY STATE;
STOMATITIS;
THROMBOCYTOPENIA;
VOMITING;
ADENOCARCINOMA;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
GENETICS;
INTRAVENOUS DRUG ADMINISTRATION;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
PATHOLOGY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
COMPARATIVE STUDY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
FEMALE;
HUMAN;
INFUSIONS, INTRAVENOUS;
ISOENZYMES;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGE;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
PROTEIN KINASE C;
PROTO-ONCOGENE PROTEINS C-RAF;
SUPPORT, NON-U.S. GOV'T;
THIONUCLEOTIDES;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
PROTEIN KINASE C-ALPHA;
|
|
EID: 0035992350
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (114)
|
|
References (19)
|
